The Heartland Study

Last updated: September 6, 2024
Sponsor: Heartland Health Research Alliance
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pregnancy Complications

Miscarriage

Pregnancy

Treatment

N/A

Clinical Study ID

NCT05492708
HHRA-HS-Phase1-2019
  • Ages > 18
  • Female
  • Accepts Healthy Volunteers

Study Summary

The Heartland Study is a prospective, observational study that will enroll up to 2,600 pregnant participants across the Heartland States in the U.S..

The objective of the Heartland Study is to address major knowledge gaps concerning the health effects of herbicides on maternal and infant health. The study is being conducted to evaluate the associations between environmental exposures to herbicides during and after pregnancy and reproductive health outcomes. The study is measuring multiple biomarkers of herbicide exposure among pregnant Midwesterners and their partners to evaluate associations with pregnancy and childbirth outcomes, epigenetic biomarkers of exposure, and child development.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Pregnant persons ages 18 or older at time of consent who are ≤20+6 weeks pregnant.Best clinical estimate of gestational age will be utilized for recruitment purposes.Enrollment in the first trimester (≤ 13 + 6) is preferred, but anyone ≤ 20 +6 ispermitted.

  • Living in one of the 13 Heartland Study region states at the time of enrollment (Arkansas, Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska,North Dakota, Ohio, South Dakota, or Wisconsin) Optional inclusion of the putativebiological father

Exclusion

Exclusion Criteria:

  • Participants who are not fluent in and/or do not fully understand, read, write, orspeak the English language.

  • Other inability to provide informed consent to participate

Study Design

Total Participants: 2600
Study Start date:
January 11, 2020
Estimated Completion Date:
January 31, 2029

Study Description

During Phase 1 of the Study, newly pregnant mothers will be enrolled less than or equal to 20 weeks + 6 days gestation and followed through to the end of pregnancy. Prenatal urine and buccal (cheek) samples will be collected to measure urinary herbicide exposure levels and to identify herbicide induced epigenetic biomarkers. Pregnancy outcomes and fetal health will be documented and analyzed to further investigate potential effects of fetal exposure. Indirect measures such as food and beverage consumption, workplace and household related chemical exposures, substance use, residential proximity to agricultural fields, and socioeconomic factors will be captured from questionnaires.

Connect with a study center

  • Franciscan Health Indianapolis

    Indianapolis, Indiana 46237
    United States

    Site Not Available

  • Indiana University Medical Center

    Indianapolis, Indiana 46202
    United States

    Active - Recruiting

  • University of Iowa Health Care

    Iowa City, Iowa 52242
    United States

    Active - Recruiting

  • Gundersen Health

    La Crosse, Wisconsin 54601
    United States

    Completed

  • Marshfield Clinic

    Marshfield, Wisconsin 54449
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.